All Type of News
Plans underway to speed up new biologicals license procedure
The government is considering shortening the period of new biological products in the process of screening their safety and efficacy by introducing the so-called mid-term assessment systemas part of its plan to ensure...
Domestic pharmaceutical firms should explore foreign markets with better R&D capacity
Korean drug makers need to reinforce their research and development (R&D) strategy toward modified new drugs and/or first generics to ensure that firms will be able to survive in the neck-and-neck international compet...
New gene therapy in Korea on the progress.
A gene therapeutic possibility showed quite a promising prospect by the local pharmaceutical industries including Dong-A, Yuhan and Kolon and the bio venture companies such as Biromed and Newgenepharm.
Biromed a...
Yuhan to regain Contac-600 prestigeYuhan Corp. said it has launched a new type of Contac-600, Contac gold, to regain its fame in the local common cold market.
A Yuhan official said that as its marketing strate...
|
KDRA dispatching global technology negotiating teams.
The Korea Drug Research Association (KDRA) formed "Global Negotiating Team for Korea and Scandinavian New Drug and BT Technology Cooperation" comprising of 14 representatives from 8 companies to dispatch to the Scandi...
Lee Seung-hoon named Novartis medical advisorNovartis Korea said it has appointed Dr. Lee Seung-hoon as a new medical advisor.
Lee, 32, will head two units of Transplantation & Immunology (IDTI) and Ophthalmics Business...
|
GWP movement is now expanding
The notion of becoming a great place to work has become recognized by a number of pharmaceutical firms as a prime means to both improve their workplace environments and, in doing so, their image and financial performa...
Health ministry disclose details of Korea-US negotiation
The Ministry of Health and Welfare disclosed on September 18 the contents of the third-round free trade agreement (FTA) between Korea and United Sates in Seattle from September 6-9, saying an intellectual property rig...
New drug policy clouds FTA
The government reaffirmed on September 18 its determination to implement a new drug-pricing measure that is aimed at offering quality medicine at a cheap price, obstacle during the third round of free trade agreement ...
A civic group to debate drug price optimizing plan.
The group for health and welfare society (GHWS) took a discussion meeting on the subject of "Debate on the May 3 Drug Price Optimizing Policy" at the conference room of Korea Chamber of Commerce on Sept. 18. The excer...
